본문 바로가기
KERD
논문KCI 등재

Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: To evaluate the expression of cellular inhibitor of apoptosis protein 2 (cIAP2) during gastric carcinogenesis after Helicobacter pylori (HP) infection and after HP eradication. Methods: We divided non-cancer patients into four groups according to the status of HP infection and atrophic gastritis (AG)/intestinal metaplasia (IM). We compared cIAP2 mRNA expression among these four groups and patients with HP-positive early gastric cancer (EGC) by using real-time polymerase chain reaction (PCR). We evaluated the expression of cIAP2 messenger RNA (mRNA)/protein by using real-time PCR/immunohistochemistry and the degree of apoptosis with a terminal deoxynucleotidyl transferasemediated nick end labeling assay before and 12 months after endoscopic submucosal dissection (ESD) in HP-positive EGC patients, regardless of whether they had undergone eradication therapy. Results: The expression of cIAP2 mRNA was significantly higher in the groups with HP(+), AG/IM(+), and HP-positive EGC than in the control, HP(+), and AG/ IM(–) groups (p<0.005). In the HP eradication group, the expression of cIAP2 mRNA/protein significantly decreased (p=0.006) and apoptosis increased at the 12-month followup after ESD. In the HP noneradication group, the aforementioned changes were not found during the same follow-up period. Conclusions: The expression of cIAP2 increased during gastric carcinogenesis after HP infection; HP eradication in the patients who had undergone ESD for EGC reversed overexpression of cIAP2 and suppressed cell apoptosis.

Abstract

Background/Aims: To evaluate the expression of cellular inhibitor of apoptosis protein 2 (cIAP2) during gastric carcinogenesis after Helicobacter pylori (HP) infection and after HP eradication. Methods: We divided non-cancer patients into four groups according to the status of HP infection and atrophic gastritis (AG)/intestinal metaplasia (IM). We compared cIAP2 mRNA expression among these four groups and patients with HP-positive early gastric cancer (EGC) by using real-time polymerase chain reaction (PCR). We evaluated the expression of cIAP2 messenger RNA (mRNA)/protein by using real-time PCR/immunohistochemistry and the degree of apoptosis with a terminal deoxynucleotidyl transferasemediated nick end labeling assay before and 12 months after endoscopic submucosal dissection (ESD) in HP-positive EGC patients, regardless of whether they had undergone eradication therapy. Results: The expression of cIAP2 mRNA was significantly higher in the groups with HP(+), AG/IM(+), and HP-positive EGC than in the control, HP(+), and AG/ IM(–) groups (p<0.005). In the HP eradication group, the expression of cIAP2 mRNA/protein significantly decreased (p=0.006) and apoptosis increased at the 12-month followup after ESD. In the HP noneradication group, the aforementioned changes were not found during the same follow-up period. Conclusions: The expression of cIAP2 increased during gastric carcinogenesis after HP infection; HP eradication in the patients who had undergone ESD for EGC reversed overexpression of cIAP2 and suppressed cell apoptosis.

참고문헌 (29)

  1. Nachmias B, "The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer", Semin Cancer Biol, 14, pp.231~243 (2004)
  2. Tamm I, "Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias", Clin Cancer Res, 6, pp.1796~1803 (2000)
  3. Conte D, "Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival", Mol Cell Biol, 26, pp.699~708 (2006)
  4. Wang CY, "NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2and c-IAP1 and c-IAP2 to suppress caspase-8 activation", Science, 281, pp.1680~1683 (1998)
  5. Miura K, "cIAP2 as a therapeutic target in colorectal cancer and other malignancies", Expert Opin Ther Targets, 13, pp.1333~1345 (2009)
  6. Esposito I, "Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer", J Clin Pathol, 60, pp.885~895 (2007)
  7. Maeda S, "Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori", Gut, 50, pp.771~778 (2002)
  8. Gupta RA, "Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells", J Biol Chem, 276, pp.31059~31066 (2001)
  9. Liu W, "Down-regulation of HSP70 sensitizes gastric epithelial cells to apoptosis and growth retardation triggered by H. pylori", BMC Gastroenterol, 11, pp.146~ (2011)
  10. Mannick EE, "Gene expression in gastric biopsies from patients infected with Helicobacter pylori", Scand J Gastroenterol, 39, pp.1192~1200 (2004)
  11. Valenzuela M, "Helicobacter pyloriinduced loss of survivin and gastric cell viability is attributable to secreted bacterial gamma-glutamyl transpeptidase activity", J Infect Dis, 208, pp.1131~1141 (2013)
  12. Yanai A, "Helicobacter pylori induces antiapoptosis through buclear factor-kappaB activation", J Infect Dis, 188, pp.1741~1751 (2003)
  13. Li Z, "A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer", Cancer Lett, 313, pp.192~200 (2011)
  14. Chang CS, "Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma", World J Gastroenterol, 10, pp.2232~2240 (2004)
  15. Choi J, "Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma", Clin Gastroenterol Hepatol, 12, pp.793~800.e1 (2014)
  16. Dixon MF, "Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1994)
  17. 강정묵, "CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer", Journal of Korean Medical Science, 26(5), pp.647~653 (2011), 대한의학회
  18. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
  19. 박희평, "Effects of sevoflurane on neuronal cell damage after severe cerebral ischemia in rats", Korean Journal of Anesthesiology, 61(4), pp.327~331 (2011), 대한마취통증의학회
  20. Uemura N, "Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer", Cancer Epidemiol Biomarkers Prev, 6, pp.639~642 (1997)
  21. Fukase K, "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial", Lancet, 372, pp.392~397 (2008)
  22. Kim YI, "The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer", Helicobacter, 19, pp.194~201 (2014)
  23. Tsai CJ, "Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy", Cancer Epidemiol Biomarkers Prev, 15, pp.272~280 (2006)
  24. Burz C, "Apoptosis in cancer: key molecular signaling pathways and therapy targets", Acta Oncol, 48, pp.811~821 (2009)
  25. Roy N, "The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases", EMBO J, 16, pp.6914~6925 (1997)
  26. Deveraux QL, "IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases", EMBO J, 17, pp.2215~2223 (1998)
  27. Kim JY, "Association of polymorphisms in virulence factor of Helicobacter pylori and gastroduodenal diseases in South Korea", J Gastroenterol Hepatol, 29, pp.984~991 (2014)
  28. Ricci MS, "Reduction of TRAIL-induced Mcl-1and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.", Cancer Cell, 12, pp.66~80 (2007)
  29. Smolewski P, "Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies", Curr Mol Med, 11, pp.633~649 (2011)

관련 논문AI추천

Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development오수연, Hyun Chae Jung, Jae Yong Park, Ji Min Choi, Joo Hyun Lim, Joo Sung Kim, Jung Kim, Sang Gyun Kim, Seung Jun Han거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제2호Helicobacter pylori Eradication Induced Constant Decrease in Interleukin- 1B Expression over More Than 5 Years in Patients with Gastric Cancer and DysplasiaChoi Sunkyu, Kim Hee Jin, Kim Nayoung, Lee Ok Jae, Park Ji Hyun, Shin Cheol Min거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제6호Helicobacter pylori Eradication Can Reverse the Methylation-Associated Regulation of miR-200a/b in Gastric CarcinogenesisHyo-Joon Yang, Hyun Chae Jung, Ji Min Choi, Joo Hyun Lim, Joo Sung Kim, Nam-Yun Cho, Sang Gyun Kim, Woo Ho Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제5호Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and AspirinHirokazu Fukui, Hiroto Miwa, Jiro Watari, Katsuyuki Tozawa, Tadayuki Oshima, Toshihiko Tomita거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제3호Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer최일주대한내과학회 · The Korean Journal of Internal Medicine2013 · 제28권 제5호Helicobacter pylori Is Associated with miR-133a Expression through Promoter Methylation in Gastric CarcinogenesisHyo-Joon Yang, Hyun Chae Jung, Ji Min Choi, Joo Hyun Lim, Joo Sung Kim, Sang Gyun Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제1호

이 간행물의 다른 논문 (26건)